Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Crescent Biopharma (CBIO) Return on Assets (2016 - 2025)

Crescent Biopharma (CBIO) has disclosed Return on Assets for 10 consecutive years, with 0.74% as the latest value for Q4 2025.

  • Quarterly Return on Assets changed N/A to 0.74% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.74% through Dec 2025, changed N/A year-over-year, with the annual reading at 0.76% for FY2023, 12.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.74% at Crescent Biopharma, down from 0.35% in the prior quarter.
  • The five-year high for Return on Assets was 0.35% in Q3 2025, with the low at 2.38% in Q1 2025.
  • Average Return on Assets over 5 years is 0.83%, with a median of 0.73% recorded in 2022.
  • Peak annual rise in Return on Assets hit 127bps in 2025, while the deepest fall reached -144bps in 2025.
  • Over 5 years, Return on Assets stood at 0.63% in 2021, then crashed by -38bps to 0.87% in 2022, then increased by 14bps to 0.75% in 2023, then crashed by -117bps to 1.62% in 2024, then soared by 55bps to 0.74% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.74%, 0.35%, and 0.45% for Q4 2025, Q3 2025, and Q2 2025 respectively.